Search hospitals

>

Washington

>

Seattle

Fred Hutchinson Cancer Research Center

Claim this profile

Seattle, Washington 98109

Global Leader in Leukemia

Global Leader in Cancer

Conducts research for Acute Myelogenous Leukemia

Conducts research for Lymphoma

Conducts research for Breast Cancer

818 reported clinical trials

105 medical researchers

Photo of Fred Hutchinson Cancer Research Center in SeattlePhoto of Fred Hutchinson Cancer Research Center in SeattlePhoto of Fred Hutchinson Cancer Research Center in Seattle

Summary

Fred Hutchinson Cancer Research Center is a medical facility located in Seattle, Washington. This center is recognized for care of Leukemia, Cancer, Acute Myelogenous Leukemia, Lymphoma, Breast Cancer and other specialties. Fred Hutchinson Cancer Research Center is involved with conducting 818 clinical trials across 997 conditions. There are 105 research doctors associated with this hospital, such as Michael J Wagner, MD, Michael Schweizer, Christina S. Baik, and Jennifer M. Specht.

Area of expertise

1

Leukemia

Global Leader

Fred Hutchinson Cancer Research Center has run 209 trials for Leukemia. Some of their research focus areas include:

HLA-A positive
HLA-A negative
HLA positive
2

Cancer

Global Leader

Fred Hutchinson Cancer Research Center has run 206 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
HER2 positive

Top PIs

Clinical Trials running at Fred Hutchinson Cancer Research Center

Breast Cancer

Prostate Cancer

Breast cancer

Pancreatic Cancer

Cancer

Acute Lymphoblastic Leukemia

Lung Cancer

Acute Myeloid Leukemia

Multiple Myeloma

Leukemia

Image of trial facility.

Letrozole

for Breast Cancer

This stage IV trial examines how a mutation in HSD3B1 (1245C) gene affects treatment of stage I-III breast cancer. This trial may help researchers determine if mutations in HSD3B1 decreases the efficacy of aromatase inhibitor therapy such as letrozole. Letrozole may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

Recruiting

3 awards

Phase 4

10 criteria

Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.

Recruiting

2 awards

Phase 3

19 criteria

Image of trial facility.

Gedatolisib + Fulvestrant +/- Palbociclib

for Advanced Breast Cancer

This trial is testing a combination of drugs to treat advanced breast cancer that has not responded to other treatments. The drugs work by blocking growth signals, breaking down estrogen receptors, and stopping cell division. Tamoxifen is a commonly used drug that blocks estrogen receptors to treat breast cancer, but resistance to it often develops.

Recruiting

2 awards

Phase 3

11 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Fred Hutchinson Cancer Research Center?

Where is Fred Hutchinson Cancer Research Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does Fred Hutchinson Cancer Research Center accept?

What awards or recognition has Fred Hutchinson Cancer Research Center received?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security